Skip Navigation LinksHome > June 2014 - Volume 30 - Issue 2 > Electroconvulsive Therapy (ECT) in Parkinson’s Disease: ECS...
Journal of ECT:
doi: 10.1097/YCT.0000000000000142
Invited Reviews

Electroconvulsive Therapy (ECT) in Parkinson’s Disease: ECS and Dopamine Enhancement

Cumper, Samantha K. BS; Ahle, Gabriella M. BA; Liebman, Lauren S. BA; Kellner, Charles H. MD

Collapse Box

Abstract

Introduction

In addition to its effects in major psychiatric illness, electroconvulsive therapy (ECT) is known to have a beneficial effect on the core motor symptoms of Parkinson’s disease (PD). This effect is believed to be mediated via dopamine in the striatum. Electroconvulsive shock (ECS), the animal analogue of ECT, is the model in which investigators have sought to elucidate the specific dopaminergic mechanisms by which ECT exerts its therapeutic effect in PD. Electroconvulsive shock has been given to intact animals as well as to animals with neurotoxic lesions that create parkinsonism.

Methods

In this paper, we selectively review the electroconvulsive shock literature on dopamine in the striatum.

Results

Electroconvulsive shock, and by extension, ECT, is associated with increased dopamine release and modulation of dopamine receptors.

Conclusion

Better understanding of how ECT works to enhance dopaminergic systems in the brain could help to make it a more accepted treatment for PD.

Copyright © 2014 by Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.